Scottish Futures Trust

The Scottish Futures Trust (SFT) is a public corporation of the Scottish Government,[1] established in September 2008 to improve public infrastructure investment. It is run by a board of seven members appointed by Scottish ministers, headed by non-executive chairman Sir Angus Grossart.

SFT operates at arm's length from the Government but works closely with the public and private sectors to deliver value-for-money on all public sector infrastructure investment across the country, with the aim of saving £100–£150 million each year through a wide range of activities.

During 2009-10, SFT saved the Scottish taxpayer £111 million, which increased to £129 million in 2010–11.[2]

In 2011-2012, SFT helped deliver £131 million of net benefits and savings to infrastructure investment which were independently validated by Grant Thornton LLP and academics from the London School of Economics and Political Science.[3]And in 2012/13, the benefits figure reached £132 million, bringing SFT's cumulative benefits to over £500 million.

There are a team of over 50 professionals at SFT, who have the responsibility of increasing the efficiency and effectiveness of infrastructure investment in Scotland.[4]

Healthcare projects that have been achieved through the SFT include the £15m Aberdeen Community Health and Care Village which opened in 2013 and the new £150m Royal Hospital for Sick Children and Department of Clinical Neurosciences in Edinburgh which is due to open in 2017.[5]

References

  1. "Public Corporations". National Public Bodies Directory. Edinburgh: The Scottish Government. Retrieved 27 November 2012.
  2. "Stripping out the 'fat' saves £129m for taxpayer". The Scotsman. 29 June 2011. Retrieved 8 September 2014.
  3. "Scottish Futures Trust 'makes £131m capital spending savings'". BBC News. 11 July 2012. Retrieved 8 September 2014.
  4. "About us: people". Scottish Futures Trust. Retrieved 8 September 2014.
  5. "Funding the future: New wave of NHS 'big build' projects". BBC News. 7 May 2014. Retrieved 9 September 2014.

See also

External links